Your browser doesn't support javascript.
loading
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves.
Wysocki, Oskar; Zhou, Cong; Rogado, Jacobo; Huddar, Prerana; Shotton, Rohan; Tivey, Ann; Albiges, Laurence; Angelakas, Angelos; Arnold, Dirk; Aung, Theingi; Banfill, Kathryn; Baxter, Mark; Barlesi, Fabrice; Bayle, Arnaud; Besse, Benjamin; Bhogal, Talvinder; Boyce, Hayley; Britton, Fiona; Calles, Antonio; Castelo-Branco, Luis; Copson, Ellen; Croitoru, Adina; Dani, Sourbha S; Dickens, Elena; Eastlake, Leonie; Fitzpatrick, Paul; Foulon, Stephanie; Frederiksen, Henrik; Ganatra, Sarju; Gennatas, Spyridon; Glenthøj, Andreas; Gomes, Fabio; Graham, Donna M; Hague, Christina; Harrington, Kevin; Harrison, Michelle; Horsley, Laura; Hoskins, Richard; Hudson, Zoe; Jakobsen, Lasse H; Joharatnam-Hogan, Nalinie; Khan, Sam; Khan, Umair T; Khan, Khurum; Lewis, Alexandra; Massard, Christophe; Maynard, Alec; McKenzie, Hayley; Michielin, Olivier; Mosenthal, Anne C.
Afiliación
  • Wysocki O; Department of Computer Science, University of Manchester, Oxford Road, Manchester M13 9PL, UK.
  • Zhou C; Digital Experimental Cancer Medicine Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, UK.
  • Rogado J; Cancer Research UK Manchester Institute, Cancer Biomarker Centre, The University of Manchester, Al-derley Park, Macclesfield SK10 4TG, UK.
  • Huddar P; Department of Medical Oncology, Hospital Universitario Infanta Leonor, Av. Gran Vía del Este, 80, 28031 Madrid, Spain.
  • Shotton R; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Tivey A; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Albiges L; Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
  • Angelakas A; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Arnold D; Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
  • Aung T; Department of Medical Oncology, Gustave Roussy, 94805 Villejuif, France.
  • Banfill K; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Baxter M; Department of Oncology, Haematology and Palliative Care, Asklepios Klinik Altona, Paul-Ehrlich-Str. 1, 22763 Hamburg, Germany.
  • Barlesi F; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S10 2JF, UK.
  • Bayle A; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Besse B; Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
  • Bhogal T; Division of Molecular and Clinical Medicine, Ninewells School of Medicine, University of Dundee, Dundee DD2 1SY, UK.
  • Boyce H; Department of Medical Oncology, Gustave Roussy, 94805 Villejuif, France.
  • Britton F; Multidisciplinary Oncology & Therapeutic Innovations Department, Aix Marseille University, CNRS, INSERM, CRCM, 13015 Marseille, France.
  • Calles A; Drug Development Department (DITEP), Gustave Roussy-Cancer Campus, 94805 Villejuif, France.
  • Castelo-Branco L; Oncostat (CESP U1018 INSERM), Labeled Ligue Contre le Cancer, University Paris-Saclay, 94805 Villejuif, France.
  • Copson E; Drug Development Department (DITEP), Gustave Roussy-Cancer Campus, 94805 Villejuif, France.
  • Croitoru A; Department of Medical Oncology, The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Dani SS; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S10 2JF, UK.
  • Dickens E; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Eastlake L; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Calle del Dr. Esquerdo, 46, 28007 Madrid, Spain.
  • Fitzpatrick P; ESMO-CoCARE Steering Committee, European Society for Medical Oncology, Via Ginevra 4, 6900 Lugano, Switzerland.
  • Foulon S; NOVA National School of Public Health, Av. Padre Cruz, 1600-560 Lisboa, Portugal.
  • Frederiksen H; Department of Medical Oncology, University Hospital Center of Algarve, R. Leao Penedo, 8000-386 Faro, Portugal.
  • Ganatra S; Cancer Sciences Academic Unit, University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton SO16 6YD, UK.
  • Gennatas S; Medical Oncology Department, Fundeni Clinical Institute, 258, Fundeni Str., 022238 București, Romania.
  • Glenthøj A; Department of Cardiology, Lahey Hospital and Medical Center, Burlington, MA 01805, USA.
  • Gomes F; Oncology Department, University Hospitals of Leicester NHS Trust, Leicester LE1 5WW, UK.
  • Graham DM; Department of Medical Oncology, University Hospitals Plymouth NHS Trust, Derriford Road, Plymouth PL6 8DH, Devon, UK.
  • Hague C; Digital Experimental Cancer Medicine Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, UK.
  • Harrington K; Oncostat (CESP U1018 INSERM), Labeled Ligue Contre le Cancer, University Paris-Saclay, 94805 Villejuif, France.
  • Harrison M; Biostatistics and Epidemiology Office, Gustave Roussy, University Paris-Saclay, 94805 Villejuif, France.
  • Horsley L; Department of Haematology, Odense University Hospital, 5000 Odense, Denmark.
  • Hoskins R; Department of Cardiology, Lahey Hospital and Medical Center, Burlington, MA 01805, USA.
  • Hudson Z; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK.
  • Jakobsen LH; Department of Haematology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
  • Joharatnam-Hogan N; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Khan S; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Khan UT; Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
  • Khan K; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Lewis A; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK.
  • Massard C; The Institute of Cancer Research NIHR Biomedical Research Centre, London SW3 6JB, UK.
  • Maynard A; Ninewells Hospital and Medical School, Dundee DD2 1SG, UK.
  • McKenzie H; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Michielin O; Research IT, University of Manchester, Oxford Road, Manchester M13 9PL, UK.
  • Mosenthal AC; Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol BS2 8ED, UK.
Cancers (Basel) ; 14(16)2022 08 16.
Article en En | MEDLINE | ID: mdl-36010932
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article